Product Information
CARBIDOPA-LEVO ER 50-200 TAB is a generic product labeled by Mylan Institutional LLC, priced at $0.1735 per EA under NDC 51079092320. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Sep 30, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50; 200 mg/1; mg/1
Manufacturer
Mylan Institutional LLCNDC
51079092320
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA075091FDA Approved
9/30/1999
TE Code
AB
On Market Since
12/1/1999
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVO ER 50-200 TAB has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 59.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1735 per EA |
|---|---|
| All-time high | $0.6666 (May 13, 2015) |
| All-time low | $0.1551 (May 22, 2024) |
| 52-week high | $0.2155 |
| 52-week low | $0.1676 |
| Median price | $0.3709 |
| Average price | $0.3472 |
| Largest weekly change | +52.4% (Jun 19, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVO ER 50-200 TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVO ER 50-200 TAB, manufactured by Mylan Institutional LLC, is $0.1735 per EA (NDC 51079092320), effective Aug 19, 2026.
How has the price of CARBIDOPA-LEVO ER 50-200 TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVO ER 50-200 TAB has declined 59.1%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVO ER 50-200 TAB?
Since Nov 28, 2013, the NADAC for CARBIDOPA-LEVO ER 50-200 TAB has ranged from a low of $0.1551 (May 22, 2024) to a high of $0.6666 (May 13, 2015), with a median of $0.3709 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVO ER 50-200 TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CARBIDOPA-LEVO ER 50-200 TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures CARBIDOPA-LEVO ER 50-200 TAB?
CARBIDOPA-LEVO ER 50-200 TAB (NDC 51079092320) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.